{"id":3314,"date":"2022-05-13T09:03:40","date_gmt":"2022-05-13T09:03:40","guid":{"rendered":"https:\/\/nuevaimdeaenergia.es\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/"},"modified":"2022-06-07T14:48:55","modified_gmt":"2022-06-07T14:48:55","slug":"virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid","status":"publish","type":"portfolio","link":"https:\/\/energia.imdea.org\/en\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/","title":{"rendered":"VIRMOF-CM: Immuno\/chemo active nanoMOFs for pulmonary multitherapy against COVID-19"},"content":{"rendered":"<div  class=\"tatsu-h1nk50vmjl1adzcd tatsu-section  tatsu-bg-overlay   tatsu-clearfix\" data-title=\"\"  data-headerscheme=\"background--dark\"><div class='tatsu-section-pad clearfix' data-padding='{\"d\":\"0px 0px 0px 0px\"}' data-padding-top='0px'><div class=\"tatsu-row-wrap  tatsu-wrap tatsu-row-one-col tatsu-row-has-one-cols tatsu-medium-gutter tatsu-reg-cols  tatsu-clearfix tatsu-h1nk50vmmwfvn0yp\" ><div  class=\"tatsu-row \" ><div  class=\"tatsu-column  tatsu-bg-overlay tatsu-one-col tatsu-column-image-none tatsu-column-effect-none  tatsu-h1nk50vmr2bjj5cs\"  data-parallax-speed=\"0\" style=\"\"><div class=\"tatsu-column-inner \" ><div class=\"tatsu-column-pad-wrap\"><div class=\"tatsu-column-pad\" ><div  class=\"tatsu-module tatsu-text-block-wrap tatsu-h1nk50vmtyby6faw  \"><div class=\"tatsu-text-inner tatsu-align-center  clearfix\" ><style>.tatsu-h1nk50vmtyby6faw.tatsu-text-block-wrap .tatsu-text-inner{width: 100%;text-align: left;}.tatsu-h1nk50vmtyby6faw.tatsu-text-block-wrap{margin: 200px 0px 0px 0px;}<\/style>\n<h4><span style=\"font-size: 28pt; color: #ffffff;\"><strong> VIRMOF-CM: Immuno\/chemo active nanoMOFs for pulmonary multitherapy against COVID-19 <\/strong><\/span><\/h4>\n<\/div><\/div><\/div><\/div><div class = \"tatsu-column-bg-image-wrap\"><div class = \"tatsu-column-bg-image\" ><\/div><\/div><div class=\"tatsu-overlay tatsu-column-overlay tatsu-animate-none\" ><\/div><\/div><style>.tatsu-row > .tatsu-h1nk50vmr2bjj5cs.tatsu-column{width: 100%;}.tatsu-h1nk50vmr2bjj5cs.tatsu-column > .tatsu-column-inner > .tatsu-column-overlay{mix-blend-mode: normal;}.tatsu-h1nk50vmr2bjj5cs > .tatsu-column-inner > .tatsu-top-divider{z-index: 9999;}.tatsu-h1nk50vmr2bjj5cs > .tatsu-column-inner > .tatsu-bottom-divider{z-index: 9999;}.tatsu-h1nk50vmr2bjj5cs > .tatsu-column-inner > .tatsu-left-divider{z-index: 9999;}.tatsu-h1nk50vmr2bjj5cs > .tatsu-column-inner > .tatsu-right-divider{z-index: 9999;}@media only screen and (max-width:1377px) {.tatsu-row > .tatsu-h1nk50vmr2bjj5cs.tatsu-column{width: 100%;}}@media only screen and (min-width:768px) and (max-width: 1024px) {.tatsu-row > .tatsu-h1nk50vmr2bjj5cs.tatsu-column{width: 100%;}}@media only screen and (max-width: 767px) {.tatsu-row > .tatsu-h1nk50vmr2bjj5cs.tatsu-column{width: 100%;}}<\/style><\/div><\/div><\/div><\/div><div class=\"tatsu-section-background-wrap\"><div class = \"tatsu-section-background\" ><\/div><\/div><div class=\"tatsu-overlay tatsu-section-overlay\"><\/div><style>.tatsu-h1nk50vmjl1adzcd .tatsu-section-background{background-image: url(http:\/\/energia.imdea.org\/wp-content\/uploads\/2022\/04\/cabe-proyectos02.jpg);background-repeat: no-repeat;background-attachment: scroll;background-position: top left;background-size: cover;}.tatsu-h1nk50vmjl1adzcd .tatsu-bg-blur{background-repeat: no-repeat;background-attachment: scroll;background-position: top left;background-size: cover;}.tatsu-h1nk50vmjl1adzcd.tatsu-section{margin: 0px 0px 80px 0px;}.tatsu-h1nk50vmjl1adzcd .tatsu-section-offset-wrap{transform: translateY(-0px);}.tatsu-h1nk50vmjl1adzcd > .tatsu-bottom-divider{z-index: 9999;}.tatsu-h1nk50vmjl1adzcd > .tatsu-top-divider{z-index: 9999;}.tatsu-h1nk50vmjl1adzcd .tatsu-section-overlay{mix-blend-mode: normal;}<\/style><\/div><div  class=\"tatsu-h1ncdeje3e604amt tatsu-section  tatsu-bg-overlay   tatsu-clearfix\" data-title=\"\"  data-headerscheme=\"background--dark\"><div class='tatsu-section-pad clearfix' data-padding='{\"d\":\"0px 0px 90px 0px\"}' data-padding-top='0px'><div class=\"tatsu-row-wrap  tatsu-wrap tatsu-row-one-col tatsu-row-has-one-cols tatsu-medium-gutter tatsu-reg-cols  tatsu-clearfix tatsu-h1ncdeje69fa2d4j\" ><div  class=\"tatsu-row \" ><div  class=\"tatsu-column  tatsu-bg-overlay tatsu-one-col tatsu-column-image-none tatsu-column-effect-none  tatsu-h1ncdeje8od2bruo\"  data-parallax-speed=\"0\" style=\"\"><div class=\"tatsu-column-inner \" ><div class=\"tatsu-column-pad-wrap\"><div class=\"tatsu-column-pad\" ><div  class=\"tatsu-module tatsu-text-block-wrap tatsu-h1ncdejebe9xo0k9  \"><div class=\"tatsu-text-inner tatsu-align-center  clearfix\" ><style>.tatsu-h1ncdejebe9xo0k9.tatsu-text-block-wrap .tatsu-text-inner{width: 100%;text-align: left;}<\/style>\n<div class=\"rtejustify\">\n<div class=\"rtejustify\">\n<p><span style=\"font-size: 14pt;\">The pandemic situation associated with the SARS-CoV-12 (COVID) outbreak has had epic social and economic repercussions worldwide. In this context, nanomedicines based on porous coordination polymers (MOFs) emerge as an original and promising alternative for its treatment, thanks to their high versatility (bioactive composition, structure) and porosity, allowing to associate different active ingredients (AIs).<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">VIRMOF-CM aims to develop a combined anti-COVID multi-therapy (4-in-1 effect) for the pulmonary route. To achieve this goal, first, nanocomposites based on MOFs and inorganic nanoparticles with intrinsic immunological and\/or chemotherapeutic activity (effect 1 &amp; 2) will be prepared. In a second step, different immuno- and\/or chemotherapeutic AIs will be associated by drug encapsulation (effect 3) and surface modification with interleukins (effect 4). Finally, the biocompatibility and efficacy of the most promising vectors will be evaluated in vitro, developing formulations adapted to pulmonary administration. Finally, their toxicity and biodistribution will be studied in vivo, leading to future preclinical and clinical research.<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">VIRMOF-CM will impact not only on anti-COVID multitherapy, but also on other pulmonary infectious diseases (tuberculosis, meningitis), as well as other relevant pathologies (cancer), opening new perspectives also in the field of prophylaxis and diagnosis.<\/span><\/p>\n<p><span style=\"font-size: 14pt;\"><strong>Partners:\u00a0<\/strong>IMDEA Energy Institute<\/span><\/p>\n<p><span style=\"font-size: 14pt;\"><strong>Funding Institution\/Program:<\/strong>\u00a0Comunidad de Madrid\u00a0\/\u00a0R&amp;D projects in response to COVID-19<\/span><\/p>\n<p><span style=\"font-size: 14pt;\"><strong>Period:<\/strong>\u00a0January 2021-December 2022<\/span><\/p>\n<p><span style=\"font-size: 14pt;\"><strong>IMDEA Energy Institute external funding:\u00a0<\/strong>1.065.000\u00a0\u20ac<\/span><\/p>\n<p><span style=\"font-size: 14pt;\"><strong>IP IMDEA Energy:<\/strong>\u00a0Dr. Patricia Horcajada<\/span><\/p>\n<p><span style=\"font-size: 14pt;\"><em>Actuaci\u00f3n financiada mediante el convenio firmado entre la Comunidad de Madrid (Consejer\u00eda de Educaci\u00f3n, Universidades, Ciencia y Portavoc\u00eda) y la Fundaci\u00f3n IMDEA Energ\u00eda para la concesi\u00f3n directa de una ayuda de 1.065.000 euros para financiar la realizaci\u00f3n de actuaciones en materia de investigaci\u00f3n sobre el SARS-COV 2 y la enfermedad COVID-19 financiado con los recursos REACT-UE del Fondo Europeo de Desarrollo<\/em>.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div><\/div><div  class=\"tatsu-single-image tatsu-module tatsu-image-lazyload tatsu-B1xLGxYLq  \" ><div class=\"tatsu-single-image-inner \" style=\"width : 558px;\" ><div class = \"tatsu-single-image-padding-wrap\" style = \"padding-bottom : 33.870967741935%;\" ><\/div><img class = \"tatsu-gradient-border\" alt = \"\" title = \"Captura de pantalla 2022-05-13 a las 11.02.07\" data-src = \"https:\/\/energia.imdea.org\/wp-content\/uploads\/2022\/05\/Captura-de-pantalla-2022-05-13-a-las-11.02.07.png\" src =\"data:image\/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mNkYAAAAAYAAjCB0C8AAAAASUVORK5CYII=\"  \/><\/div><style>.tatsu-B1xLGxYLq .tatsu-single-image-inner{border-style: solid;max-width: 100%;}.tatsu-B1xLGxYLq.tatsu-single-image{transform: translate3d(0px,0px, 0);}<\/style><\/div><\/div><\/div><div class = \"tatsu-column-bg-image-wrap\"><div class = \"tatsu-column-bg-image\" ><\/div><\/div><div class=\"tatsu-overlay tatsu-column-overlay tatsu-animate-none\" ><\/div><\/div><style>.tatsu-row > .tatsu-h1ncdeje8od2bruo.tatsu-column{width: 100%;}.tatsu-h1ncdeje8od2bruo.tatsu-column > .tatsu-column-inner > .tatsu-column-overlay{mix-blend-mode: normal;}.tatsu-h1ncdeje8od2bruo > .tatsu-column-inner > .tatsu-top-divider{z-index: 9999;}.tatsu-h1ncdeje8od2bruo > .tatsu-column-inner > .tatsu-bottom-divider{z-index: 9999;}.tatsu-h1ncdeje8od2bruo > .tatsu-column-inner > .tatsu-left-divider{z-index: 9999;}.tatsu-h1ncdeje8od2bruo > .tatsu-column-inner > .tatsu-right-divider{z-index: 9999;}<\/style><\/div><\/div><\/div><\/div><div class=\"tatsu-section-background-wrap\"><div class = \"tatsu-section-background\" ><\/div><\/div><div class=\"tatsu-overlay tatsu-section-overlay\"><\/div><style>.tatsu-h1ncdeje3e604amt .tatsu-section-pad{padding: 0px 0px 90px 0px;}.tatsu-h1ncdeje3e604amt > .tatsu-bottom-divider{z-index: 9999;}.tatsu-h1ncdeje3e604amt > .tatsu-top-divider{z-index: 9999;}.tatsu-h1ncdeje3e604amt .tatsu-section-overlay{mix-blend-mode: normal;}<\/style><\/div>\n","protected":false},"excerpt":{"rendered":"<p><a href=\"https:\/\/energia.imdea.org\/en\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/\" class=\"more-link style1-button\">Read More<\/a><\/p>","protected":false},"author":3,"featured_media":3315,"menu_order":0,"comment_status":"open","ping_status":"closed","template":"","format":"standard","meta":{"_vp_format_video_url":"","_vp_image_focal_point":[],"footnotes":""},"portfolio_category":[],"portfolio_tag":[],"class_list":["post-3314","portfolio","type-portfolio","status-publish","format-standard","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VIRMOF-CM: Immuno\/chemo active nanoMOFs for pulmonary multitherapy against COVID-19 - IMDEA ENERG\u00cdA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/energia.imdea.org\/en\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VIRMOF-CM: Immuno\/chemo active nanoMOFs for pulmonary multitherapy against COVID-19 - IMDEA ENERG\u00cdA\" \/>\n<meta property=\"og:url\" content=\"https:\/\/energia.imdea.org\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/\" \/>\n<meta property=\"og:site_name\" content=\"IMDEA ENERG\u00cdA\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-07T14:48:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/energia.imdea.org\/wp-content\/uploads\/2022\/05\/VIRMOF-CM.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/energia.imdea.org\\\/porfolio\\\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\\\/\",\"url\":\"https:\\\/\\\/energia.imdea.org\\\/porfolio\\\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\\\/\",\"name\":\"VIRMOF-CM: Immuno\\\/chemo active nanoMOFs for pulmonary multitherapy against COVID-19 - IMDEA ENERG\u00cdA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/energia.imdea.org\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/energia.imdea.org\\\/porfolio\\\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/energia.imdea.org\\\/porfolio\\\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/energia.imdea.org\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/VIRMOF-CM.jpg\",\"datePublished\":\"2022-05-13T09:03:40+00:00\",\"dateModified\":\"2022-06-07T14:48:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/energia.imdea.org\\\/porfolio\\\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/energia.imdea.org\\\/porfolio\\\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/energia.imdea.org\\\/porfolio\\\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\\\/#primaryimage\",\"url\":\"https:\\\/\\\/energia.imdea.org\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/VIRMOF-CM.jpg\",\"contentUrl\":\"https:\\\/\\\/energia.imdea.org\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/VIRMOF-CM.jpg\",\"width\":500,\"height\":333},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/energia.imdea.org\\\/porfolio\\\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/energia.imdea.org\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Portfolio\",\"item\":\"http:\\\/\\\/energia.imdea.org\\\/en\\\/portfolio\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"VIRMOF-CM: Immuno\\\/chemo active nanoMOFs for pulmonary multitherapy against COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/energia.imdea.org\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/energia.imdea.org\\\/en\\\/\",\"name\":\"IMDEA ENERG\u00cdA\",\"description\":\"Otro sitio realizado con WordPress\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/energia.imdea.org\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VIRMOF-CM: Immuno\/chemo active nanoMOFs for pulmonary multitherapy against COVID-19 - IMDEA ENERG\u00cdA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/energia.imdea.org\/en\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/","og_locale":"en_US","og_type":"article","og_title":"VIRMOF-CM: Immuno\/chemo active nanoMOFs for pulmonary multitherapy against COVID-19 - IMDEA ENERG\u00cdA","og_url":"https:\/\/energia.imdea.org\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/","og_site_name":"IMDEA ENERG\u00cdA","article_modified_time":"2022-06-07T14:48:55+00:00","og_image":[{"width":500,"height":333,"url":"https:\/\/energia.imdea.org\/wp-content\/uploads\/2022\/05\/VIRMOF-CM.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/energia.imdea.org\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/","url":"https:\/\/energia.imdea.org\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/","name":"VIRMOF-CM: Immuno\/chemo active nanoMOFs for pulmonary multitherapy against COVID-19 - IMDEA ENERG\u00cdA","isPartOf":{"@id":"https:\/\/energia.imdea.org\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/energia.imdea.org\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/#primaryimage"},"image":{"@id":"https:\/\/energia.imdea.org\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/#primaryimage"},"thumbnailUrl":"https:\/\/energia.imdea.org\/wp-content\/uploads\/2022\/05\/VIRMOF-CM.jpg","datePublished":"2022-05-13T09:03:40+00:00","dateModified":"2022-06-07T14:48:55+00:00","breadcrumb":{"@id":"https:\/\/energia.imdea.org\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/energia.imdea.org\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/energia.imdea.org\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/#primaryimage","url":"https:\/\/energia.imdea.org\/wp-content\/uploads\/2022\/05\/VIRMOF-CM.jpg","contentUrl":"https:\/\/energia.imdea.org\/wp-content\/uploads\/2022\/05\/VIRMOF-CM.jpg","width":500,"height":333},{"@type":"BreadcrumbList","@id":"https:\/\/energia.imdea.org\/porfolio\/virmof-cm-nanomofs-inmuno-quimio-activos-para-la-multiterapia-pulmonar-anti-covid\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/energia.imdea.org\/en\/"},{"@type":"ListItem","position":2,"name":"Portfolio","item":"http:\/\/energia.imdea.org\/en\/portfolio\/"},{"@type":"ListItem","position":3,"name":"VIRMOF-CM: Immuno\/chemo active nanoMOFs for pulmonary multitherapy against COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/energia.imdea.org\/en\/#website","url":"https:\/\/energia.imdea.org\/en\/","name":"IMDEA ENERG\u00cdA","description":"Otro sitio realizado con WordPress","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/energia.imdea.org\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/energia.imdea.org\/en\/wp-json\/wp\/v2\/portfolio\/3314","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/energia.imdea.org\/en\/wp-json\/wp\/v2\/portfolio"}],"about":[{"href":"https:\/\/energia.imdea.org\/en\/wp-json\/wp\/v2\/types\/portfolio"}],"author":[{"embeddable":true,"href":"https:\/\/energia.imdea.org\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/energia.imdea.org\/en\/wp-json\/wp\/v2\/comments?post=3314"}],"version-history":[{"count":0,"href":"https:\/\/energia.imdea.org\/en\/wp-json\/wp\/v2\/portfolio\/3314\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/energia.imdea.org\/en\/wp-json\/wp\/v2\/media\/3315"}],"wp:attachment":[{"href":"https:\/\/energia.imdea.org\/en\/wp-json\/wp\/v2\/media?parent=3314"}],"wp:term":[{"taxonomy":"portfolio_category","embeddable":true,"href":"https:\/\/energia.imdea.org\/en\/wp-json\/wp\/v2\/portfolio_category?post=3314"},{"taxonomy":"portfolio_tag","embeddable":true,"href":"https:\/\/energia.imdea.org\/en\/wp-json\/wp\/v2\/portfolio_tag?post=3314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}